Background Cancer treatments are associated with a multitude of adverse events (AEs). While both nurses and physicians are involved in patient care delivery and AE assessment, very few studies have examined the differences between nurses’ and physicians’ reporting and perception of AEs. An approach was recently proposed to assess treatment burden based on reported AEs from the physician’s perspective. In this paper, we use this approach to evaluate nurses’ perception of burden, and compare nurses’ and physicians’ assessment of the overall and relative burden of AEs. Methods AE records for 334 cancer patients from a randomized clinical trial conducted by the SWOG C...
Objective: To develop a validated measure of professionals' attitudes towards clinical adverse event...
The National Cancer Institute (NCI) is developing a patient-reported version of its Common Terminolo...
Toxicity of chemotherapy is a factor that most negatively affects the quality of life of cancer pati...
Background: Monitoring adverse events during chemotherapy by clinicians is a standard practice but c...
Symptomatic adverse event (AE) monitoring is essential in cancer clinical trials to assess patient s...
Symptomatic adverse events (AEs) are monitored by clinicians as part of all US-based clinical trials...
The National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) reporting...
Purpose Adverse symptom event reporting is vital as part of clinical trials and drug labeling to ens...
Background: The National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminol...
Objectives: This study aimed to describe the cancer nurses’ views regarding the relevance of cancer ...
ABSTRACT: BACKGROUND: Many patients with advanced cancer depend upon health care providers for sympt...
Approximately 1.5 million people are diagnosed with cancer each year. Most of these people will expe...
PURPOSE: Developments in cancer treatments have resulted in increased survival of patients, but side...
Many patients with advanced cancer depend upon health care providers for symptom assessment. The ext...
Purpose Information about symptomatic toxicities of anticancer treatments is not based on direct re...
Objective: To develop a validated measure of professionals' attitudes towards clinical adverse event...
The National Cancer Institute (NCI) is developing a patient-reported version of its Common Terminolo...
Toxicity of chemotherapy is a factor that most negatively affects the quality of life of cancer pati...
Background: Monitoring adverse events during chemotherapy by clinicians is a standard practice but c...
Symptomatic adverse event (AE) monitoring is essential in cancer clinical trials to assess patient s...
Symptomatic adverse events (AEs) are monitored by clinicians as part of all US-based clinical trials...
The National Cancer Institute’s Common Terminology Criteria for Adverse Events (NCI-CTCAE) reporting...
Purpose Adverse symptom event reporting is vital as part of clinical trials and drug labeling to ens...
Background: The National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminol...
Objectives: This study aimed to describe the cancer nurses’ views regarding the relevance of cancer ...
ABSTRACT: BACKGROUND: Many patients with advanced cancer depend upon health care providers for sympt...
Approximately 1.5 million people are diagnosed with cancer each year. Most of these people will expe...
PURPOSE: Developments in cancer treatments have resulted in increased survival of patients, but side...
Many patients with advanced cancer depend upon health care providers for symptom assessment. The ext...
Purpose Information about symptomatic toxicities of anticancer treatments is not based on direct re...
Objective: To develop a validated measure of professionals' attitudes towards clinical adverse event...
The National Cancer Institute (NCI) is developing a patient-reported version of its Common Terminolo...
Toxicity of chemotherapy is a factor that most negatively affects the quality of life of cancer pati...